Biosimilar formulation development requires navigating around scientific, regulatory, and legal challenges, according to Sung ...
How Gundry MD's H2MG React™ Effervescent Delivery System, Citicoline, and Methylcobalamin B12 Address the Key Variables ...
For healthcare investors, few catalysts matter more than success in a Phase III clinical trial, the last major hurdle before ...
The FDA has published new guidance aimed at reducing or stopping toxicity studies of monoclonal antibody-based drugs in non-human primates (NHPs), in the latest stage of an ongoing effort to reduce ...
Testing helps reduce regulatory risk by showing whether key controls are working, what has changed and what evidence exists ...
A 90-day testing cycle does not just fall short of that number. It runs straight into it. The reality is that modern ...
As the prevalence of liver disease continues to climb alongside diabetes and obesity, the role of the primary care physician is evolving from referral maker to frontline manager.
Post-collision OEM safety inspections can reveal failures no scan will show. Two shop leaders explain why these inspections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results